SCN5A mutation identified in a patient with short-coupled variant of torsades de pointes.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
05 2020
Historique:
received: 10 12 2019
revised: 27 03 2020
accepted: 19 04 2020
pubmed: 24 4 2020
medline: 19 5 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

Short-coupled variant of torsades de pointes (scTdP) is a disease characterized by TdP without QT prolongation, which is initiated by extremely short-coupled ventricular extra-systoles. Its genetic background remains rarely unveiled. We aimed to identify genetic variations in patients with scTdP and to analyze the functional change of the mutant Na We performed genetic analysis for inherited arrhythmia-related 45 genes using next-generation sequencer (MiSeq, Illumina) among seven consecutive scTdP patients. We identified an SCN5A mutation R800H in a 38-year-old male who suffered ventricular fibrillation during dinner and was resuscitated. Two months later, he lost his consciousness at work. His Holter electrocardiogram showed scTdP. He had no family history of sudden cardiac death or heart disease. Functional analysis of the SCN5A-R800H channels showed a significantly shortened recovery time from inactivation. Peak sodium current densities in SCN5A-R800H were larger than those in wild type but the difference was not statistically significant. We identified an SCN5A mutation in a scTdP patient and confirmed that the mutant channel caused the shortness of recovery time from inactivation. SCN5A might be a candidate gene for scTdP.

Sections du résumé

BACKGROUND
Short-coupled variant of torsades de pointes (scTdP) is a disease characterized by TdP without QT prolongation, which is initiated by extremely short-coupled ventricular extra-systoles. Its genetic background remains rarely unveiled.
OBJECTIVE
We aimed to identify genetic variations in patients with scTdP and to analyze the functional change of the mutant Na
METHODS AND RESULTS
We performed genetic analysis for inherited arrhythmia-related 45 genes using next-generation sequencer (MiSeq, Illumina) among seven consecutive scTdP patients. We identified an SCN5A mutation R800H in a 38-year-old male who suffered ventricular fibrillation during dinner and was resuscitated. Two months later, he lost his consciousness at work. His Holter electrocardiogram showed scTdP. He had no family history of sudden cardiac death or heart disease. Functional analysis of the SCN5A-R800H channels showed a significantly shortened recovery time from inactivation. Peak sodium current densities in SCN5A-R800H were larger than those in wild type but the difference was not statistically significant.
CONCLUSIONS
We identified an SCN5A mutation in a scTdP patient and confirmed that the mutant channel caused the shortness of recovery time from inactivation. SCN5A might be a candidate gene for scTdP.

Identifiants

pubmed: 32323320
doi: 10.1111/pace.13924
doi:

Substances chimiques

NAV1.5 Voltage-Gated Sodium Channel 0
SCN5A protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-461

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Leenhardt A, Glaser E, Burguera M, Nurnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation. 1994;89:206-215.
Lemery R, Brugada P, Della Bella P, Dugernier T, Wellens HJ. Ventricular fibrillation in six adults without overt heart disease. J Am Coll Cardiol. 1989;13:911-916.
Viskin S, Lesh MD, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol. 1997;8:1115-1120.
Bogaard K, van der Steen MS, Tan HL, Tukkie R. Short-coupled variant of torsade de pointes. Neth Heart J. 2008;16:246-249.
Fujii Y, Itoh H, Ohno S, et al. A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia. Heart Rhythm. 2017;14:98-107.
Ohno S, Zankov DP, Ding WG, et al. KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol. 2011;4:352-361.
Wilde AAM, Amin AS. Clinical spectrum of SCN5A mutations: long qt syndrome, Brugada syndrome, and cardiomyopathy. JACC Clin Electrophysiol. 2018;4:569-579.
Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest. 2008;118:2219-2229.
Hayama Y, Kaitani K, Onishi N, et al. Ablation of idiopathic ventricular fibrillation targeting short coupled ventricular premature contractions originating from a right ventricular papillary muscle. J Cardiol Cases. 2014;9:113-116.
Dessertenne F. Ventricular tachycardia with 2 variable opposing foci. Arch Mal Coeur Vaiss. 1966;59:263-272.
Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation. 2002;106:962-967.
Xiao L, Koopmann TT, Ordog B, et al. Unique cardiac Purkinje fiber transient outward current beta-subunit composition: a potential molecular link to idiopathic ventricular fibrillation. Circ Res. 2013;112:1310-1322.
Haissaguerre M, Shah DC, Jais P, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet. 2002;359:677-678.
Yeh DD, Lu JT, Kim A, Yeh RW, Scheinman MM. Calcium-triggered short-coupled polymorphous ventricular tachycardia. Pacing Clin Electrophysiol. 2007;33:117-122.
Makiyama T, Akao M, Shizuta S, et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol. 2008;52:1326-1334.
Lieve KV, Verkerk AO, Podliesna S, et al. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation. Int J Cardiol. 2017;236:187-193.

Auteurs

Keiko Sonoda (K)

Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Japan.
Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Seiko Ohno (S)

Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Japan.
Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.
Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Shiga, Japan.

Yukiko Shimizu (Y)

Department of Cardiovascular Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Kazuaki Kaitani (K)

Department of Cardiovascular Medicine, Japanese Red Cross Otsu Hospital, Otsu, Japan.

Takeru Makiyama (T)

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yoshihisa Nakagawa (Y)

Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.

Minoru Horie (M)

Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.
Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Shiga, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH